Cancel
Nearby: Atlanta, GA 30308

Access Your Account

New to Healthgrades?

Join for free!

Or, sign in directly with Healthgrades:

Doctors and their Administrators:
Sign Up or Log In

How Immunotherapy Treats Advanced Renal Cell Carcinoma

By

Marijke Vroomen Durning, RN

Was this helpful? (22)
This content is selected and managed by the Healthgrades editorial staff and is brought to you by an advertising sponsor.
x

This content is created or selected by the Healthgrades editorial team and is funded by an advertising sponsor. The content is subject to the Healthgrades medical review process for accuracy, balance and objectivity. The content is not edited or otherwise influenced by the advertisers appearing on this page except with the possible suggestion of the broad topic area. For more information, read the HealthGrades advertising policy.

ADVERTISEMENT

Get the FREE "Fighting Cancer With Immunotherapy" email series.  You will receive six emails with EXCLUSIVE content on immunotherapy.

*

Which of the following conditions are you MOST interested in?

By clicking "Get Started" I agree to Healthgrade's privacy policy  and user agreement.
gloved-hand-holding-vial

We don’t seem to hear a lot about kidney cancer (renal cell carcinoma), but it’s among the 10 most common cancers in the United States. Over 60,000 people every year in the U.S. are diagnosed with it. Unfortunately, because most symptoms don’t become obvious until the tumors are larger, many people are diagnosed with kidney cancer only after it has progressed to later stages, when it is called advanced renal cell carcinoma.

For many years, treatment options for advanced renal cell carcinoma were limited. Traditional chemotherapy isn’t as effective on advanced renal cell carcinoma as it is on other types of cancer and when it is effective, the cancer often returns within a few years and is more difficult to treat.

What is immunotherapy, and how can it fight cancer? These experts explain this exciting new treatment.

2016 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

Using Immunotherapy to Fight Advanced Renal Cell Carcinoma

Immunotherapy, also called biologic therapy or biotherapy, is a treatment that uses your immune system to fight a disease it normally might not recognize, such as cancer. The therapy can do this by stimulating your immune system to attack cancer cells or tumors, or by giving you specific immune system proteins that will act on the cells. One of the biggest advantages of immunotherapy over chemotherapy is immunotherapy attacks only the cancer cells without affecting the healthy cells in the body, reducing the number and severity of possible side effects.

Types of Immunotherapy

Research into different types of immunotherapy is ongoing. Currently there are four main types that can be used to treat advanced renal cell carcinoma and even more are being studied.

Immune checkpoint inhibitors: Tumor genes can express proteins that fool the immune system to think no threat is present. Immune checkpoint inhibitors help your immune system by blocking these proteins. The reawakened immune system can recognize the cancer cells and directly attack them. Because your immune system is looking for these specific tumor proteins, it doesn’t attack healthy cells. There are different classes of checkpoint inhibitors, depending on what part of the cell they target. Checkpoint inhibitors currently used for treatment of advanced renal cell carcinoma include nivolumab (Opdivo) and iIpilimumab (Yervoy).

Angiogenesis inhibitors: Some cancer tumors grow by developing new blood vessels, which allow the tumors to gather the nutrients they need. Immunotherapy agents called angiogenesis inhibitors stop the tumors’ ability to do this. Bevacizumab (Avastin) is one of the angiogenesis inhibitors used to treat advanced renal cell carcinoma.

Targeted therapies: Targeted therapies allow drugs to directly block enzymes tumors use to grow and multiply. These targeted therapies include sunitinib (Sutent), pazopanib (Votrient) and everolimus (Afinitor), among others. While these are not technically immunotherapies, they are often put together in this group because of the way they target the cancer cells.

Therapeutic vaccines. Most of us are familiar with the traditional vaccines we use to prevent illnesses, such as polio and tetanus. Therapeutic vaccines work differently and are given to patients who have a disease rather than to prevent it. When a therapeutic vaccine is given to someone with a disease like advanced renal cell carcinoma, it triggers the immune system to fight against it. These vaccines are still in clinical trials, but results are promising.

Immunotherapy Side Effects

As with all medications, immunotherapy can cause side effects in some people. However because immunotherapy targets the cancer cells alone, the risk of side effects is lower than with chemotherapy. And if side effects do occur, they are generally less severe. Side effects can include:

Was this helpful? (22)
Medical Reviewers: William C. Lloyd III, MD, FACS Last Review Date: Dec 23, 2016

© 2016 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

View Sources

Medical References

  1. Targeted therapies for kidney cancer. American Cancer Society. http://www.cancer.org/cancer/kidneycancer/detailedguide/kidney-cancer-adult-treating-targeted-therapy
  2. What is cancer immunotherapy? American Cancer Society. http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/immunotherapy/immunotherapy-what-is-immunotherapy
  3. Renal Cell Cancer Treatment (PDQ®)–Patient Version. National Cancer Institute. Part of the National Institutes of Health. https://www.cancer.gov/types/kidney/patient/kidney-treatment-pdq#section/_50
  4. Kidney Cancer. Cancer Research Institute. http://www.cancerresearch.org/cancer-immunotherapy/impacting-all-cancers/kidney-cancer

Your opinion matters!



Please fill out this short, 1-3 minute survey about Advances in Immunotherapy. Your answers are anonymous and will not be linked to you personally.

The survey will appear at the end of your visit.

Thank you!

A survey will be presented to you after you finish viewing our Advances in Immunotherapy content.

You Might Also Like

Share via Email

PREVIOUS ARTICLE:

5 Facts About Immunotherapy for Head and Neck Cancer

NEXT ARTICLE:

Advances in Treating Late-Stage Lung Cancer

Up Next

Advances in Treating Late-Stage Lung Cancer